BioMed Central (United Kingdom)

BioMed Central (United Kingdom)

BioMed Central is a United Kingdom-based, for-profit scientific open access publisher that produces over 250 scientific journals. All its journals are published online only. BioMed Central describes itself as the first and largest open access science publisher. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for BioMed Central (United Kingdom), United Kingdom, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

92%


Total
Publications

515


Total Open
Publications

472


Total
Citations

8K


Open Access
Percentage

92%


Total
Publications

515


Total Open
Publications

472


Total
Citations

8K

Wikipedia

Website

download

Breakdown

16% 76% 0% 8%

Publisher Open

16%

Both

76%

Other Platform Open

0%

Closed

8%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

77%OA Journal

OA Journal 77%

364

Hybrid 16%

74

No Guarantees 7%

32

Other Platform Open

Domain 83%

325

Other Internet 22%

85

Institution 8%

33

Public 1%

3

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
322
Europe PMC
Domain
93
DOI
Other Internet
84
DANS - Data Archiving and Networked Services
Institution
6
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
5
Université Libre de Bruxelles - Dépôt institutionnel de l'Université libre de Bruxelles
Institution
4
University of Edinburgh - Edinburgh Research Explorer
Institution
3
iu.edu OAI-PMH Repository
Institution
3
Zenodo
Public
2
University of Tromsø - Septentrio Academic Publishing
Institution
2
1 / 4

Data updated 18 August 2025

Share

Share

Share